2[2]Ratko T,Cummings J,Oberman H,et al.Evidence-based recommendations for the use of WBC-reduced cellular blood components[J].Transfusion,2001,41(10):1310-1319.
3[4]Cardigan R,Phipps A,Seghatchian J,et al.The development of a national standardized approach for the enumeration of residual leueocytes in blood components[J].Vox Sang,2002,83(2):100～109.
4[5]Seghatehian J,Krailadsiri P,Scott CS.Counting of residual WBCs in WBC-reduced blood eomponents:a muhieenter evaluation of a micmvolume fluorimeter by the United Kingdom National Blood Setviee[J].Transfusion,2001,41(1):93～101.
2Cryopreserved platelets:apheresis. In :Council of Europe publishing, eds. Guide to the preparation, use and quality assurance of blood components [M]. Stras Bourg Cedex: Council of Europe , 2001:141-142.
3Bamard MR,MacGreger H,Ragno G, et al. Fresh,liquid-Pre served and Cryopreserved platelets:adhesive surface receptors and membrane procoagulant activity[J]. Transfusion ,1999; 39(8):880.
